The role of the D-dimer in the diagnosis of venous thromboembolism

Seminars in Respiratory and Critical Care Medicine

Volumn 21, Issue 6, 2000, Pages 521-536

  Ahearn, G S ^a   Bounameaux, H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

D dimer; Deep venous thrombosis; Enzyme linked immunosorbent assay; Pulmonary embolism; Thromboembolism

Indexed keywords

D DIMER;

ALGORITHM; DEEP VEIN THROMBOSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG EMBOLISM; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; VEIN DISEASE;

EID: 0034525160     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13186     Document Type: Review

References (95)

1. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
2. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles
3. D-dimer testing in suspected venous thromboembolism: An update
4. Deep vein thrombosis: New non-invasive tests
5. Detection of asymptomatic deep vein thrombosis by real-time B-mode ultrasonography in hip surgery patients
6. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline
7. The place of D-dimer testing in an integrated approach of patients suspected of pulmonary embolism
8. D-dimers, thrombin antithrombin III complexes and prothrombin fragments F1 + 2: Diagnostic value in clinically suspected deep vein thrombosis
9. Is quantitative determination of fibrin(ogen) degradation products and anti-thrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
10. Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit?
11. D-dimer and TAT measurement in patients with deep venous thrombosis: Utility in diagnosis and judgement of anticoagulant treatment effectiveness
12. D-dimer and thrombin anti-thrombin III complexes in patients with clinically suspected pulmonary embolism
13. Pulmonary embolism: Efficacy of D-dimer and thrombin anti-thrombin III complex determinations as screening tests before lung scanning
14. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma
15. Measurement of crosslinked fibrin degradation products: An immunoassay using monoclonal antibodies
16. Measurement of cross-linked fibrin derivatives: Use in the diagnosis of venous thrombosis
17. Assessment of D dimer assays for the diagnosis of deep vein thrombosis
18. Assesment of D-dimer in plasma: Diagnostic value in the suspected deep venous thrombosis of the leg
19. The use of D-dimer assay by enzyme immunoassay and latex agglutination techniques in the diagnosis of deep vein thrombosis
20. Comparison of the appropriateness of the latex and elisa plasma D-dimer determination for the diagnosis of deep venous thrombosis
21. Comparison of three D-dimer assays for the diagnosis of DVT: ELISA, latex and an immunofiltration assay (Nyocard D-dimer)
22. Measurement of plasma D-dimer for diagnosis of deep venous thrombosis
23. Assesment of D-dimer measurement by ELISA or latex methods in deep vein thrombosis diagnosed by ultrasound duplex scanning
24. The use of the D-dimer test in combination with non-invasive testing versus serial non-invasive testing for the diagnosis of deep-vein thrombosis
25. D-dimer and thrombin/anti-thrombin III complex-diagnostic tools in deep venous thrombosis?
26. D-dimer plasma measurement in patients undergoing major hip surgery: Use in the prediction and diagnosis of postoperative proximal vein thrombosis
27. D-dimer test and diagnosis of deep vein thrombosis: A comparative study of 7 assays
28. Rapid quantitative D-dimer assay and the clinical evaluation for the diagnosis of clinically suspected DVT
29. Diagnostic value of a new sensitive membrane based technique for instantaneous D-dimer evaluation in patients with clinically suspected deep venous thrombosis
30. D-dimer strategy in thrombosis exclusion
31. Comparison of various D-dimer tests for the diagnosis of deep vein thrombosis
32. Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: Use in the diagnosis of postoperative venous thrombosis
33. Investigations into the clinical utility of the latex D-dimer in the diagnosis of deep venous thrombosis
34. Application of a bedside whole blood D-dimer assay in the diagnosis of deep vein thrombosis
35. Comparison of new rapid methods for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients
36. Contribution of a new, rapid, quantitative and automated method for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients
37. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis
38. Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis
39. Failure of soluble fibrin polymers in the diagnosis of clinically suspected deep vein thrombosis
40. D-dimer plasma concentrations in various clinical conditions: Implications for the use of this test in the diagnostic approach of venous thromboembolism
41. Plasma D-dimer in suspected pulmonary embolism: A comparison with pulmonary angiography and ventilation perfusion scintigraphy
42. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism
43. A new quantitative D-dimer assay appropriate in emergency: Reliability of the assay for pulmonary embolism exclusion diagnosis
44. Diagnostic value of two rapid and individual D-dimer assays in patients with clinically suspected pulmonary embolism: Comparison with microplate enzyme-linked immunoabsorbant assay
45. D-dimer testing for suspected pulmonary embolism in outpatients
46. D-dimers in the diagnosis of pulmonary embolism
47. A new semi-quantitative and individual ELISA for rapid measurement of plasma D-dimer in patients suspected of pulmonary embolism
48. Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism
49. Diagnostic value of plasma D-dimer in suspected pulmonary embolism
50. D-dimer in patients with clinically suspected pulmonary embolism
51. Complementarity of lung scintigraphy and D-dimer test in pulmonary embolism
52. Pulmonary embolism in patients with intermediate probability lung scans: Diagnosis with doppler venous US and D-dimer measurement
53. Comparison of four rapid D-dimer tests for diagnosis of pulmonary embolism
54. Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism
55. An immunoassay for human D-dimer using monoclonal antibodies
56. D-dimer latex assay as screening method in suspected deep venous thrombosis of the leg. A clinical study and review of the literature
57. Diagnostic value of compression ultrasonography and fibrinogen-related parameters for the detection of postoperative deep vein thrombosis following elective hip replacement: A pilot study
58. Utility of D-dimer in the diagnosis of deep vein thrombosis in outpatients
59. 2 and D-dimer
60. Normal D-dimer levels in patients with pulmonary embolism
61. Use of the alveolar dead space fraction (Vd/Vt) and plasma D-dimers to exclude acute pulmonary embolism in ambulatory patients
62. Plasma D-dimer: A useful tool for evaluating suspected pulmonary embolus
63. The application of a rapid D-dimer test in suspected pulmonary embolus
64. Assay of D-dimer based on immunofiltration and staining with gold colloids
65. Plasma D-dimer measurement in patients with suspected DVT: A means of avoiding unnecessary venography
66. Comparison of immunofiltration assay of D-dimer with diagnostic imaging in deep vein thrombosis
67. Clinical evaluation of a diagnostic strategy for deep venous thrombosis with exclusion by low plasma levels of fibrin degradation product D-dimer
68. Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients
69. Whole blood immunoassay (SimpleRED) versus plasma immunoassay (NycoCard) for the diagnosis of clinically suspected deep vein thrombosis
70. Evaluation of a new rapid quantitative D-dimer assay in patients with clinically suspected deep vein thrombosis
71. Non-invasive diagnosis of venous thromboembolism in outpatients
72. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis
73. Clinical evaluation of an immunoturbidimetric D-dimer assay in the diagnostic procedure of deep vein thrombosis and pulmonary embolism
74. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients
75. Contribution of a new, rapid, individual and quantitative D-dimer ELISA to exclude pulmonary embolism
76. Usefulness of D-dimer, blood gas and respiratory rate measurements for excluding pulmonary embolism
77. Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism
78. Sensitivity and specificity of a whole-blood assay for D-dimer in the diagnosis of pulmonary embolism
79. A new sensitive membrane based ELISA technique for instantaneous D-dimer evaluation in emergency
80. The SimpliRED D dimer test: A novel assay for the detection of crosslinked fibrin degradation products in whole blood
81. Rapid D-dimer testing as an adjunct to clinical findings in excluding pulmonary embolism
82. Evaluation of a new, rapid, and quantitative D-dimer test in patients with suspected pulmonary embolism
83. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay
84. The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis
85. D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep venous thrombosis: Prospective cohort study
86. Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)
87. Contribution of D-dimer plasma measurement and lower-limb venous ultrasound to the diagnosis of pulmonary embolism: A decision analysis model
88. Diagnosis of pulmonary embolism by a decision analysis based strategy including clinical probability, D-dimer levels and ultrasonography: A management study
89. Elevated D-dimer levels in patients admitted to the medical intensive care unit (MICU): Prevalence and association with outcomes
90. A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes in critically ill patients
91. Value of liquid crystal contact thermography and plasma levels of D-dimer for screening of deep venous thrombosis after general surgery
92. Current concepts in thrombosis: Prevalent trends for the diagnosis and management
93. Clinical usefulness of D-dimer tests in excluding pulmonary embolism is highly dependent upon age
94. Which factors affect high D-dimer levels in the elderly?
95. Influence of age on the hemostatic system: Prothrombin fragment F1 + 2, thrombin antithrombin III complexes and D-dimers in 80 healthy subjects with age range from 20 to 94 years